TNFSF10 and neoplasm: The tumor microenvironment plays an important role in modulating the efficacy of both the endogenous TRAIL/TRAIL-R system, used by immune cells, as well as of exogenously administrated therapeutic TRAIL receptor agonists (de Looff et al., 2019).